Nexviadyme 100 mg, poudre pour solution à diluer pour perfusion

7680678710017 CH-67871 Puder
Nexviadyme 100 mg, poudre pour solution à diluer pour perfusion
Nexviadyme 100 mg, poudre pour solution à diluer pour perfusion
Nexviadyme 100 mg, poudre pour solution à diluer pour perfusion
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Puder
Galenic group
Spray/Puder

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
30/09/2024
Summary of Product Characteristics
Français
30/09/2024
Summary of Product Characteristics
Italien
30/09/2024

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 1049.55
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2023

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
67871
Drug name
Nexviadyme, poudre pour solution à diluer pour perfusion
Galenic form
PULPI
ATC Code
A16AB22
Authorization status
Z
Dispensing category
A
First authorization
17/11/2021
Authorization expiration date
16/11/2026
IT Number
07.14.0.
Domain
Human medicine

Package details

Description (FR)
NEXVIADYME subst sèche 100 mg flac
Description (DE)
NEXVIADYME Trockensub 100 mg Durchstf
Market launch
17/11/2021
Narcotic (BTM)
No

Other package sizes (2)

NEXVIADYME subst sèche 100 mg flac 5 pce
5 DUR
GTIN: 7680678710024
View
NEXVIADYME subst sèche 100 mg flac 10 pce
10 DUR
GTIN: 7680678710031
View